Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Dec 22, 2020
Targets & Mechanisms
Tissue-targeting autoantibodies as a driver of long COVID
...study co-leader Aaron Ring, an assistant professor of
immunobiology
...
Read More
BioCentury
|
Aug 11, 2020
Product Development
Remdesivir heads for FDA review as Gilead continues to build manufacturing pipeline
...follow-up was 27 days from treatment to discharge, with a range of 16-90 days.Reported in
Immunobiology
...
Read More
BioCentury
|
Jan 4, 2020
Targets & Mechanisms
SIGLECs go from homing beacons to next-generation checkpoints
...lymphocyte (TIL) function, and a March study from the lab of NextCure founder and Yale
immunobiology
...
Read More
BioCentury
|
Nov 5, 2019
Clinical News
NextCure’s NC318 data shines light on SIGLEC15 as next hot IO target
...and acts as a suppressor of antigen-specific T cell responses. Chen is a professor of
immunobiology
...
Read More
BioCentury
|
Sep 19, 2019
Product Development
Anokion’s autoimmunity platform evolution
...to humans. “What we’ve found is that there are substantial similarities across species in the
immunobiology
...
Read More
BioCentury
|
Jun 11, 2019
Company News
Why Brii Bio partnered with microbiome start-up Artizan
...Flavell is a professor of
immunobiology
at Yale, where Palm is an assistant professor of
immunobiology
...
Read More
BioCentury
|
Mar 4, 2019
Preclinical News
NextCure's macrophage-based alternative to T cell checkpoint inhibitors
...extend their uses to non-responders or patients who develop resistance. Chen is a professor of
immunobiology
...
Read More
BioCentury
|
Feb 1, 2019
Tools & Techniques
TMB needs company
...October in Science , the company said the markers represent “two central aspects of tumor
immunobiology
”...
Read More
BioCentury
|
Nov 9, 2018
Company News
NextCure, Lilly partner to find new immuno-oncology targets
...an antibody against sialic acid binding Ig like lectin 15 (SIGLEC15). Chen, a professor of
immunobiology
...
Read More
BioCentury
|
Nov 5, 2018
Company News
NextCure, Lilly partner to find new immuno-oncology targets
...an antibody against sialic acid binding Ig like lectin 15 (SIGLEC15). Chen, a professor of
immunobiology
...
Read More
Items per page:
10
1 - 10 of 62
BioCentury
|
Dec 22, 2020
Targets & Mechanisms
Tissue-targeting autoantibodies as a driver of long COVID
...study co-leader Aaron Ring, an assistant professor of
immunobiology
...
Read More
BioCentury
|
Aug 11, 2020
Product Development
Remdesivir heads for FDA review as Gilead continues to build manufacturing pipeline
...follow-up was 27 days from treatment to discharge, with a range of 16-90 days.Reported in
Immunobiology
...
Read More
BioCentury
|
Jan 4, 2020
Targets & Mechanisms
SIGLECs go from homing beacons to next-generation checkpoints
...lymphocyte (TIL) function, and a March study from the lab of NextCure founder and Yale
immunobiology
...
Read More
BioCentury
|
Nov 5, 2019
Clinical News
NextCure’s NC318 data shines light on SIGLEC15 as next hot IO target
...and acts as a suppressor of antigen-specific T cell responses. Chen is a professor of
immunobiology
...
Read More
BioCentury
|
Sep 19, 2019
Product Development
Anokion’s autoimmunity platform evolution
...to humans. “What we’ve found is that there are substantial similarities across species in the
immunobiology
...
Read More
BioCentury
|
Jun 11, 2019
Company News
Why Brii Bio partnered with microbiome start-up Artizan
...Flavell is a professor of
immunobiology
at Yale, where Palm is an assistant professor of
immunobiology
...
Read More
BioCentury
|
Mar 4, 2019
Preclinical News
NextCure's macrophage-based alternative to T cell checkpoint inhibitors
...extend their uses to non-responders or patients who develop resistance. Chen is a professor of
immunobiology
...
Read More
BioCentury
|
Feb 1, 2019
Tools & Techniques
TMB needs company
...October in Science , the company said the markers represent “two central aspects of tumor
immunobiology
”...
Read More
BioCentury
|
Nov 9, 2018
Company News
NextCure, Lilly partner to find new immuno-oncology targets
...an antibody against sialic acid binding Ig like lectin 15 (SIGLEC15). Chen, a professor of
immunobiology
...
Read More
BioCentury
|
Nov 5, 2018
Company News
NextCure, Lilly partner to find new immuno-oncology targets
...an antibody against sialic acid binding Ig like lectin 15 (SIGLEC15). Chen, a professor of
immunobiology
...
Read More
Items per page:
10
1 - 10 of 62
Previous page
Next page